Option Care Health, Inc. Common Stock
OPCH
$20.33
-24.34%
Option Care Health, Inc. is a leading provider of home and alternate-site infusion services, operating within the healthcare sector's medical care facilities industry. The company is a distinct player as the nation's largest independent provider of infusion services, offering a critical, cost-effective alternative to hospital-based care for treatments ranging from bleeding disorders to chronic inflammatory conditions. The current investor narrative is likely focused on the company's ability to capitalize on the secular trend of healthcare moving to lower-cost settings, though recent stock price weakness suggests debate over near-term growth execution, reimbursement pressures, or competitive dynamics within its single-segment business model.…
OPCH
Option Care Health, Inc. Common Stock
$20.33
OPCH 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Option Care Health, Inc. Common Stock's 12-month outlook, with a consensus price target around $26.43 and implied upside of +30.0% versus the current price.
Average Target
$26.43
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$16 - $26
Analyst target range
Analyst coverage for OPCH is extremely limited, with only two analysts providing estimates, which implies this is a small or mid-cap stock with lower institutional interest, leading to potentially higher volatility and less efficient price discovery. The consensus estimates project revenue of $8.33 billion and EPS of $2.85 for the period ahead, with a relatively tight range between the low and high EPS estimates of $2.81 and $2.90, suggesting some agreement on the near-term earnings trajectory despite the sparse coverage. No explicit price targets, buy/hold/sell ratings, or institutional rating trends are available in the data, preventing a calculation of implied upside or an assessment of analyst sentiment bias, which further underscores the stock's profile as one with minimal Wall Street scrutiny.
OPCH Technical Analysis
The stock is in a pronounced downtrend, having declined 21.04% over the past year and currently trading near the bottom of its 52-week range, approximately 11% above its 52-week low of $24.24. This positioning near multi-month lows suggests the stock is in a value-seeking zone but carries significant 'falling knife' risk if the fundamental outlook continues to deteriorate. Recent momentum is decisively negative and accelerating the longer-term downtrend, with the stock down 11.96% over the past month and 14.80% over the past three months, indicating sustained selling pressure without meaningful relief rallies. The stock's beta of 0.95 indicates its volatility is roughly in line with the broader market, but its severe underperformance, evidenced by a -43.24% 1-year relative strength versus the SPY, points to significant company-specific or sector-specific headwinds rather than broad market weakness. Key technical support is firmly established at the 52-week low of $24.24, while resistance sits at the 52-week high of $36.80; a breakdown below $24.24 would signal a new phase of technical weakness, whereas a recovery above the recent March highs near $30 would be necessary to suggest the downtrend is abating.
Beta
0.95
0.95x market volatility
Max Drawdown
-44.4%
Largest decline past year
52-Week Range
$18-$37
Price range past year
Annual Return
-37.1%
Cumulative gain past year
| Period | OPCH Return | S&P 500 |
|---|---|---|
| 1m | -24.5% | +10.5% |
| 3m | -40.2% | +3.9% |
| 6m | -21.9% | +5.4% |
| 1y | -37.1% | +29.6% |
| ytd | -36.9% | +5.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OPCH Fundamental Analysis
Revenue trajectory analysis is constrained as specific quarterly revenue and growth rate figures are not available in the provided data; however, analyst estimates suggest expected annual revenue of approximately $8.33 billion, indicating the company operates at a significant scale within its sector. The company is profitable, reporting a net margin of 3.67% and a gross margin of 19.26%, though the operating margin of 5.98% suggests a relatively high cost structure between gross profit and operating income, which is typical for asset-intensive service businesses. Profitability metrics show a trailing Return on Equity (ROE) of 15.65% and Return on Assets (ROA) of 6.14%, which indicate moderate but positive efficiency in generating profits from shareholder equity and company assets, respectively. Balance sheet health appears solid based on limited data, with a current ratio of 1.53 suggesting adequate short-term liquidity, though the absence of debt-to-equity and free cash flow figures prevents a full assessment of leverage and internal funding capacity for growth.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OPCH Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 24.29x and a forward PE of 12.92x; the significant discount of the forward multiple implies the market expects a substantial near-term increase in earnings, aligning with the analyst EPS estimate of $2.85. Peer comparison is limited without industry average multiples provided, but the stock's Price-to-Sales (PS) ratio of 0.89x and EV-to-Sales of 0.94x suggest a valuation grounded in sales rather than high-margin earnings, which is consistent with its low net margin profile. Historical context is unavailable due to missing historical ratios data, preventing an assessment of whether the current trailing PE of 24.29x is near the top or bottom of its own historical range, which would help gauge if the stock is pricing in optimistic or pessimistic expectations relative to its own history.
PE
24.3x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.1x
Enterprise Value Multiple

